Tumor therapy with targeted atomic nanogenerators

Science

Volumn 294, Issue 5546, 2001, Pages 1537-1540

  McDevitt, M R ^a   Ma, D ^a   Lai, L T ^a   Simon, J ^a   Borchardt, P ^a   Frank, R K ^a   Wu, K ^a   Pellegrini, V ^a   Curcio, M J ^a   Miederer, M ^a   Bander, N H ^a   Scheinberg, D A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ENERGY TRANSFER; ISOTOPES; TOXICITY; TUMORS;

NANOGENERATORS;

CELLS;

ACTINIUM; ASTATINE 211; ISOTOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B 4; MONOCLONAL ANTIBODY J 591; MONOCLONAL ANTIBODY M 195; UNCLASSIFIED DRUG;

MEDICINE;

ANIMAL CELL; ARTICLE; ATOMIC PARTICLE; CANCER CELL; CANCER SURVIVAL; CANCER THERAPY; CELL KILLING; DRUG DELIVERY SYSTEM; ENERGY TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

ACTINIUM; ALPHA PARTICLES; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HALF-LIFE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; IMMUNOCONJUGATES; LINEAR ENERGY TRANSFER; LYMPHOMA; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOIMMUNOTHERAPY; SURVIVAL RATE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0035900395     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1064126     Document Type: Article

References (25)